Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
life sciences
merck
3
×
national blog main
new york blog main
raleigh-durham blog main
san diego blog main
san francisco blog main
3
×
san francisco top stories
seattle blog main
seattle top stories
arvinas
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer diagnostics
deals
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national
national top stories
new york top stories
raleigh-durham top stories
san diego top stories
san francisco
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
10x genomics
abbvie
adverum biotechnologies
albert bourla
alzheimer's disease
amgen
amicus therapeutics
antibiotics
What
company
3
×
make
acquisitions
adding
aims
albert
biggest
bio
biotechs
bourla
ceo
chose
close
crispr
deal
decisions
device
diagnostic
diagnostics
drug
expand
firms
fold
future
help
imports
ipo
ipos
life
maker
maps
measured
medical
nanostring
open
patients
pfizer
pfizer’s
physicians
q
Language
unknown
unset
Current search:
merck
×
company
×
" san francisco blog main "
×
@xconomy.com
4 years ago
Veracyte Aims to Expand Diagnostics Reach With $50M NanoString Deal
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
5 years ago
Six Life Science Firms Close Q3 with an IPO, More Are on the Way